Jazz Pharmaceuticals Insider Sold Shares Worth $19,207,098, According to a Recent SEC Filing

MT newswire2026/09/01 07:42

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

03:42 AM EDT, 09/01/2026 (MT Newswires) -- Robert Iannone, Executive Vice President, Global Head of Research and Development and Chief Medical Officer, on August 27, 2026, sold 76,921 shares in Jazz Pharmaceuticals (JAZZ) for $19,207,098. Following the Form 4 filing with the SEC, Iannone has control over a total of 65,686 ordinary shares of the company, with 65,686 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1232524/000173732926000016/xslF345X05/edgardoc.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.

华尔街见闻•2026/11/10 18:41